Diosmetin Exerts Synergistic Effects in Combination with 5-Fluorouracil in Colorectal Cancer Cells
5-Fluorouracil (5-FU) is a chemotherapeutic medication commonly used to treat colorectal cancer (CRC); however, the drug-associated adverse effects and toxicity have greatly affected its clinical use. Exploring another therapeutic strategy that lowers the toxicity of 5-FU while having a synergistic...
Main Authors: | Sareh Kamran, Ajantha Sinniah, Zamri Chik, Mohammed Abdullah Alshawsh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/3/531 |
Similar Items
-
Evaluation of Anti-Tumorigenic Effects of Diosmetin against Human Colon Cancer Xenografts in Athymic Nude Mice
by: Sanaz Koosha, et al.
Published: (2019-07-01) -
Can We Improve Diosmetin Activity? The State-of-the-Art and Promising Research Directions
by: Monika Wujec, et al.
Published: (2023-12-01) -
Feng-liao-chang-wei-kang is synergistic with 5-fluorouracil in inhibiting proliferation of colorectal cancer
by: Pan-Li Ni, et al.
Published: (2019-01-01) -
Preparation and pharmacokinetic study of diosmetin long-circulating liposomes modified with lactoferrin
by: Wen-Xia Sun, et al.
Published: (2022-04-01) -
Synergistic role of thymoquinone and 5-fluorouracil in U-251MG glioblastoma cell line
by: Mutlu Altundağ Ergül, et al.
Published: (2023-12-01)